[1] Rudnicka L, et al. European expert consensus statement on the systemic treatment of alopecia areata. J Eur Acad Dermatol Venereol. 2024;38(4):687-94.
[2] 国家药品监督管理局. 【2023-3-25】https://www.nmpa.gov.cn/zwfw/sdxx/sdxxyp/yppjfb/20230325145930100.html
[3] 国家药监局批准甲苯磺酸利特昔替尼胶囊上市. 2023-10-19 https://www.nmpa.gov.cn/zhuanti/cxylqx/cxypxx/20231019161001181.html
[4] Husein-ElAhmed H, et al. Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta-analysis. J Eur Acad Dermatol Venereol. 2024 May;38(5):835-843.
[5] King B, et al. Two Phase 3 Trials of Baricitinib for Alopecia Areata. N Engl J Med. 2022 May 5;386(18):1687-1699.
[6] Kwon O，et al.AAD 2022 march 25-29,20.
[7] M. Senna, et al. AAD 2024 Abstract #49690.
[8] King B, et al. AAD 2024 Abstract&Poster #52874.
[9] B. King, et al. AAD 2024 Poster #51436
[10] 巴瑞替尼说明书.
